The Extreme Ends of the Treatment Response Spectrum to Botulinum Toxin in Cervical Dystonia by Sara Samadzadeh, Raphaela Brauns, Harald Hefter

Get full text

The Impact of SARS-CoV-2 Pandemic Lockdown on a Botulinum Toxin Outpatient Clinic in Germany by Sara Samadzadeh, Raphaela Brauns, Dietmar Rosenthal, Harald Hefter

Get full text

The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia by Harald Hefter, Isabelle Schomaecker, Max Schomaecker, Dietmar Rosenthal, Sara Samadzadeh

Subjects: Get full text

Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot Study by Harald Hefter, Isabelle Schomaecker, Max Schomaecker, Beyza Ürer, Raphaela Brauns, Dietmar Rosenthal, Philipp Albrecht, Sara Samadzadeh

Subjects: Get full text

“Pseudo”-Secondary Treatment Failure Explained via Disease Progression and Effective Botulinum Toxin Therapy: A Pilot Simulation Study by Harald Hefter, Dietmar Rosenthal, Sara Samadzadeh

Subjects: Get full text

Transient Improvement after Switch to Low Doses of RimabotulinumtoxinB in Patients Resistant to AbobotulinumtoxinA by Harald Hefter, Sara Samadzadeh, Marek Moll

Subjects: Get full text

Continuous Increase of Efficacy under Repetitive Injections of Botulinum Toxin Type/A beyond the First Treatment for Adult Spastic Foot Drop by Harald Hefter, Werner Nickels, Dietmar Rosenthal, Sara Samadzadeh, Philipp Albrecht

“…The objective of this study was to quantify the increase in efficacy during the first four cycles of treatment with botulinum toxin type/A (BoNT/A) in 24 free-walking BoNT/A naïve adult patients with post-stroke hemispasticity and spastic foot drop. …”
Get full text

Enhanced Effect of Botulinum Toxin A Injections into the Extensor Digitorum Brevis Muscle after Local Mechanical Leg Vibration: A Case Report by Harald Hefter, Judith Beek, Dietmar Rosenthal, Sara Samadzadeh

Subjects: Get full text

The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation—A Monocentric Cross-Sectional Pilot Study by Harald Hefter, Isabelle Schomaecker, Max Schomaecker, Dietmar Rosenthal, Sara Samadzadeh

Subjects: Get full text

Clinical Implications of Difference in Antigenicity of Different Botulinum Neurotoxin Type A Preparations: Clinical Take-Home Messages from Our Research Pool and Literature by Sara Samadzadeh, Beyza Ürer, Raphaela Brauns, Dietmar Rosenthal, John-Ih Lee, Philipp Albrecht, Harald Hefter

Subjects: “…complex proteins: botulinum toxin type A…”
Get full text

Effective Treatment of Neurological Symptoms with Normal Doses of Botulinum Neurotoxin in Wilson’s Disease: Six Cases and Literature Review by Harald Hefter, Sara Samadzadeh

“…Despite the evidence that copper can interfere with the botulinum toxin in preclinical models, patients with WD do not require higher doses of the toxin than other patients with dystonia.…”
Get full text